Literature DB >> 6601502

Glucocorticoids and lymphocytes. III. Effects of glucocorticoid administration on lymphocyte glucocorticoid receptors.

G F Shipman, C D Bloomfield, K J Gajl-Peczalska, A U Munck, K A Smith.   

Abstract

To determine the effects of glucocorticoid administration on the number of measured lymphocyte glucocorticoid receptor sites and the duration of such effects, seven normal volunteers were studied. Glucocorticoid receptor levels of the lymphocytes circulating in the blood of each volunteer were determined. Glucocorticoid was then administered in a regimen of a total of four doses of dexamethasone 4 mg p.o. every 6 hr. Determinations of the number of receptors were performed at 6 hr and at various subsequent times after the end of dexamethasone administration. When compared to baseline receptor numbers, six volunteers showed a decrease in receptor number after glucocorticoid administration (median maximum decrease 2,046 sites/cell). The fall in receptor number occurred rapidly, reaching a nadir within 30 hr from the end of glucocorticoid administration. The return of receptor number to baseline was more gradual, requiring from 3 to as long as 17 days in one subject. Our results suggest that in order to accurately interpret glucocorticoid receptor numbers in human lymphoid cells, glucocorticoid should not have been administered for 3 wk prior to determinations of receptor levels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601502

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.

Authors:  Mark P Yeager; Athos J Rassias; Patricia A Pioli; Michael L Beach; Kathleen Wardwell; Jane E Collins; Hong-Kee Lee; Paul M Guyre
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

2.  High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.

Authors:  R Towers; T Naftali; G Gabay; M Carlebach; A Klein; B Novis
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Action of compounds with effective in vivo mineralocorticoid activity on ion transport in leucocytes.

Authors:  D N Baron; R J Green
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

4.  Elevated white blood cell counts in Cushing's disease: association with hypercortisolism.

Authors:  Hiba Masri-Iraqi; Eyal Robenshtok; Gloria Tzvetov; Yossi Manistersky; Ilan Shimon
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

5.  In vivo exposure to high or low cortisol has biphasic effects on inflammatory response pathways of human monocytes.

Authors:  Mark P Yeager; Patricia A Pioli; Kathleen Wardwell; Michael L Beach; Peter Martel; Hong K Lee; Athos J Rassias; Paul M Guyre
Journal:  Anesth Analg       Date:  2008-11       Impact factor: 5.108

6.  Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells.

Authors:  Eva Kassi; Narjes Nasiri-Ansari; Eliana Spilioti; Vassiliki Kalotychou; Panagiota E Apostolou; Paraskevi Moutsatsou; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2016-05-24       Impact factor: 9.261

7.  Decreased mineralocorticoid receptor expression in blood cells of kidney transplant recipients undergoing immunosuppressive treatment: cost efficient determination by quantitative PCR.

Authors:  P J Heering; N Klein-Vehne; K Fehsel
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

8.  Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.

Authors:  Rohini Ramakrishnan; Debra C DuBois; Richard R Almon; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

9.  Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Barbara Tomaszewska; Ryszard Wierciński; Anna Stasiak-Barmuta
Journal:  Pediatr Nephrol       Date:  2003-06-12       Impact factor: 3.714

10.  Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process.

Authors:  G S Madretsma; A P Dijk; C J Tak; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.